About Us

Overview

SK biotek (SKBT), an SK pharmteco, is a global CDMO with ~ 360 m³ of capacity globally. With state-of-the-art facilities in Korea and Ireland specilaising in the manufacturing cGMP API and Advanced Intermediates via Advance Synthesis, Continuous Flow Processing and High Containment, from grams to multi-tons across the full product lifecycle for global innovative pharmaceutical companies.

SKBT is considered a world-leader in Continuous Flow Processing and the manufacture of High Potency API. World-class facilities and technologies in Korea and Ireland, with two state-of-the-art facilities in Korea, an R&D facility in Daejeon and a large scale manufacturing and pilot plant in Sejong and a further facility at Swords Campus, Co. Dublin, Ireland, which specializes in the supply of clinical and commercial API.
The state of the art facility in Swords has been manufacturing API and Intermediates for nearly 60 years. For the last 30 years, Swords Campus has maintained its leadership in the development, scale-up and commercial manufacture of highly potent chemical intermediates and API. For over 20 years, Swords Campus has been the launch manufacturing site and centre of excellence for APIs for one of the world’s leading pharmaceutical companies. With exceptional technical capabilities within R&D, with extensive experience in custom development from clinical phases to commercial launch, scale-up for products. SK biotek can today offer multi-scale plants (from grams to 100s of kg) capable of handling material with Occupational Exposure Limit (OEL) ≤ 10 ng/m³.

As leaders in operational excellence and continuous improvement and boasting exceptional technical capabilities, Swords Campus provides a strong offering to our customers through scale-up, launch and secure commercial supply of new chemical entities. Our integrated facility combines manufacturing plants, R&D and QC laboratories within the same building. Within the general Campus capabilities, we offer access to world-class potent handling capability (down to low nanogram per cubic meter levels) and have a strong material science group on Campus. Through the implementation of strong safety compliance policy and adherence to high-quality and safety standards, Swords Campus has a proven track record as a reliable supplier of HPAPIs to multiple customers.

Our plants in Korea offer cost effective supply of late phase and commercial pharmaceutical API and Intermediates. Our scientists and engineers are leading exponents of continuous manufacturing methodologies (tubular and fixed bed reactions) and have successfully developed processes from low kilograms through to 10s of tonnes. Continuous Flow Processing can offer many advantages over traditional batch processing. It is not just greener, highly efficient and often cost effective, it also provides access to low temperature, hazardous, and catalytic reactions.
SK has the capability and capacity to support all your API and Intermediate needs across the full lifecycle.
As an SK customer, we commit to work with you and your product as if it were our own; after all, we have been doing it for decades, producing many of the world’s most recognized drugs.